Clinical and laboratory characteristics of 144 patients with Mediterranean spotted fever

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 22, Issue 2, 2003, Pages 126-128

  Anton E ^a   Font, B ^a   Munoz T ^a   Sanfeliu, I ^a   Segura, F ^a  

^a Hospital Universitari Parc Taulí   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; CLARITHROMYCIN; DOXYCYCLINE; JOSAMYCIN;

ARTICLE; BOUTONNEUSE FEVER; CLINICAL FEATURE; CLINICAL TRIAL; COUGHING; DISEASE CARRIER; FEVER; GASTROINTESTINAL SYMPTOM; HEADACHE; HEPATOMEGALY; HUMAN; INCIDENCE; MYALGIA; PRIORITY JOURNAL; RASH; RICKETTSIA CONORII; SERODIAGNOSIS; SYMPTOM; TICK;

EID: 0037298937     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-002-0879-x     Document Type: Article

References (10)

1. Raoult D, Weiller JP, Chagnon A, Chaudet H, Gallais H, Casanova P (1986) Mediterranean spotted fever: clinical, laboratory and epidemiological features of 199 cases. Am J Trop Med Hyg 35:845-850
2. Font B, Bella F, Espejo E, Vidal R, Muñoz T, Nolla M, Casagran A, Mercade J, Segura F (1985) Mediterranean spotted fever: a cooperative study of 227 cases. Rev Infect Dis 7:635-642
3. Font B, Espejo E, Muñoz T, Uriz S, Bella F, Segura F (1991) Fiebre botonosa mediterránea. Estudio de 246 casos. Med Clin (Barc) 96:121-125
4. Raoult D, Gallais H, Ottomani A, Resch JP, Tichadou D, de Micco P, Casanova P (1983) La forme maligne de la fièvre boutonneuse méditerranéene. Presse Med 12:2375-2378
5. Yagupsky P (2000) Mortality in serologically unconfirmed Mediterranean spotted fever. J Infect Dis 181:809-810
6. Segura F, Font B (1982) Resurgence of Mediterranean spotted fever in Spain. Lancet 2:280
7. Espejo E, Font B, Bella F, Segura F (1986) Climatic factors in resurgence of Mediterranean spotted fever. Lancet 1:1333
8. Bella F, Font B, Segura F, Espejo E, López P, Muñoz T (1987) Comparative, randomized trial of one-day doxycycline versus 10-day tetracycline therapy for Mediterranean spotted fever. J Infect Dis 155:1056-1058
9. Ives TJ, Marston EL, Regnery RL, Butts JD, Majerus TC (2000) In vitro susceptibilities of Rickettsia and Bartonella spp. to 14-hydroxy-clarithromycin as determined by immunofluorescent antibody analysis of infected Vero cell monolayers. J Antimicrob Chemother 45:305-310
10. Cascio A, Colomba C, Di Rosa D, Salsa L, di Martino L, Titone L (2001) Efficacy and safety of clarithromycin as treatment for Mediterranean spotted fever in children: a randomized controlled trial. Clin Infect Dis 33:409-411